During the past decade, Centro Medico Dalinde conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 3 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro Medico Dalinde" #1 collaborator was "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator and "Institut Jules Bordet/Clinical Trials Support Unit (IJB/CTSU)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Centro Medico Dalinde" are "Breast Cancer" (2 trials), "Rheumatoid Arthritis" (2 trials), "Triple Negative Breast Cancer" (2 trials), "Cancer" (1 trials) and "Carcinoma, Hepatocellular" (1 trials). Many other conditions were trialed in "Centro Medico Dalinde" in a lesser frequency.

Most popular intervention types in "Centro Medico Dalinde" are "Drug" (11 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Atezolizumab" (5 trials), "Paclitaxel" (2 trials), "Atezolizumab (MPDL3280A), an engineered anti-PDL1 antibody" (1 trials) and "Bevacizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro Medico Dalinde" are 11 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Centro Medico Dalinde". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Centro Medico Dalinde, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centro Medico Dalinde, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".